Number | 44 | 109 | 82 | |
Age (years) | 65.7 (10.1) | 61.7 (10.6) | 55.6 (8.9) | <0.000001† |
Men | 50% | 55.9% | 71.9% | 0.02 |
Hypertension | 81.8% | 75.2% | 45.1% | <0.000001† |
Diabetes | 22.7% | 15.6% | 11.0% | 0.22 |
Dyspnoea | 65.9% | 55.0% | 35.4% | 0.002 |
Pulmonary disease | 11.3% | 13.8% | 14.6% | 0.88 |
Coronary artery disease | 54.5% | 42.2% | 31.7% | 0.04 |
Ejection fraction (%) | 72.2 (8.2) | 72.8 (8.4) | 70.9 (8.9) | 0.50 |
Angiographic EDV (ml) | 131.3 (38.3) | 136.3 (40.0) | 133.9 (32.0) | 0.85 |
EDV/BSA (ml/m2) | 70.0 (17.1) | 69.9 (18.5) | 67.1 (14.9) | 0.85 |
Angiographic ESV (ml) | 40.3 (24.7) | 37.5 (20.1) | 39.3 (17.6) | 0.76 |
Total cholesterol (mmol/l) | 5.40 (1.18) | 5.43 (1.18) | 5.48 (1.19) | 0.86 |
LDL cholesterol (mmol/l) | 3.13 (1.10) | 3.18 (1.01) | 3.29 (1.07) | 0.72 |
HDL cholesterol (mmol/l) | 1.39 (0.40) | 1.45 (0.44) | 1.35 (0.42) | 0.33 |
Triglycerides (mmol/l) | 1.96 (0.03) | 1.84 (0.99) | 2.09 (1.58) | 0.62 |
Creatinine clearance (ml/s) | 1.17 (0.39) | 1.37 (0.51) | 1.57 (0.47) | 0.000009† |
Body height (cm) | 166.8 (9.1) | 168.8 (8.8) | 171.4 (8.1) | 0.007 |
SBP brachial (mm Hg) | 142.9 (21.4) | 140.8 (20.7) | 130.5 (17.6) | 0.0002† |
DBP brachial (mm Hg) | 78.4 (11.5) | 83.3 (13.6) | 80.1 (11.7) | 0.10 |
PP brachial (mm Hg) | 65.5 (15.8) | 57.9 (15.3) | 50.5 (13.9) | 0.000003† |
SBP aortic (mm Hg) | 134.2 (21.2) | 131.3 (20.3) | 120.1 (17.0) | 0.00002† |
DBP aortic (mm Hg) | 79.3 (11.7) | 84.1 (13.7) | 80.9 (11.8) | 0.10 |
PP aortic (mm Hg) | 54.9 (15.5) | 47.6 (14.5) | 39.5 (13.2) | <0.000001† |
Aspirin | 88.6% | 75.2% | 73.2% | 0.12 |
β blockers | 72.7% | 56.9% | 46.3% | 0.02 |
Calcium channel blockers | 25% | 17.4% | 8.5% | 0.04 |
ACE inhibitor/ARB | 50% | 51.4% | 35.4% | 0.07 |
Nitrates | 22.7% | 11.9% | 14.6% | 0.24 |
Statins | 34.1% | 29.4% | 34.1% | 0.74 |
Diuretics | 31.8% | 25.7% | 18.3% | 0.22 |